Murigenics, Inc

Cureline is a global contract research organization (CRO) specializing in human biospecimen services, including biobanking and laboratory analysis, to support accelerated drug research and development since its inception in 2003. With a robust global clinical network and regulatory expertise, Cureline offers a diverse array of high-quality biospecimens and custom protocols tailored for various therapeutic areas, including oncology, infectious diseases, and neurological disorders. The company operates an extensive HBS biorepository located in the San Francisco Bay area, providing validated human biospecimens for biomarker development and translational research. Cureline has collaborated with over 150 clinical sites worldwide and has successfully completed projects for approximately 700 clients while actively participating in significant NIH scientific consortiums. Generated from the website

SanBio is a regenerative medicine company based in Mountain View, California, focused on developing innovative therapies for neurological conditions. Their flagship product, SB623, utilizes advanced stem cell technology to offer potential treatment solutions for patients. With a commitment to enhancing patient outcomes through cutting-edge research and development, SanBio aims to lead advancements in the field of regenerative medicine. The company showcases a strong dedication to collaboration and growth within the healthcare sector. Generated from the website

Hoffmann-La Roche, also known as Roche, is prescription drug unit that provides more than 35 medications in the United States in therapeutic areas, including dermatology, oncology, transplantation, AIDS, central nervous system disorders, and cardiovascular and infectious diseases. It offers products that include Accutane, Boniva, CellCept, Copegus, Cytovene, Demadex EC-Naprosyn, Romazicon, Tamiflu, Ticlid, Valcyte, Valium, Xeloda, Xenical and Zenapax. The company operates over five research centers in New Jersey and California in the United States, as well as Switzerland, Germany and China. Hoffmann-La Roche works with a team of nearly 5,000 employees. It is a part of Roche Group, which is one of the world's leading research-oriented health care groups with core businesses in pharmaceuticals and diagnostics. Operational for more than 100 years, the parent company develops a range of products and services that address prevention, diagnosis and treatment of diseases.